PortfoliosLab logoPortfoliosLab logo
CURE vs. ERX
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

CURE vs. ERX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily Healthcare Bull 3x Shares (CURE) and Direxion Daily Energy Bull 2X Shares (ERX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CURE achieves a -9.94% return, which is significantly lower than ERX's 64.27% return. Over the past 10 years, CURE has outperformed ERX with an annualized return of 13.02%, while ERX has yielded a comparatively lower -9.26% annualized return.


CURE

1D
-0.69%
1M
18.27%
YTD
-9.94%
6M
-3.58%
1Y
30.33%
3Y*
3.28%
5Y*
1.60%
10Y*
13.02%

ERX

1D
2.24%
1M
8.51%
YTD
64.27%
6M
60.89%
1Y
88.96%
3Y*
21.63%
5Y*
28.42%
10Y*
-9.26%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CURE vs. ERX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CURE
Direxion Daily Healthcare Bull 3x Shares
-9.94%22.55%-8.47%-9.40%-20.51%88.30%5.02%55.66%2.82%69.32%
ERX
Direxion Daily Energy Bull 2X Shares
64.27%2.79%1.09%-12.26%130.58%111.91%-91.60%17.13%-55.94%-11.60%

Correlation

The correlation between CURE and ERX is -0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.01

Correlation (3Y)
Calculated over the trailing 3-year period

0.13

Correlation (5Y)
Calculated over the trailing 5-year period

0.19

Correlation (10Y)
Calculated over the trailing 10-year period

0.29

Correlation (All Time)
Calculated using the full available price history since Jun 16, 2011

0.38

The correlation between CURE and ERX shifts across timeframes, from -0.01 (1 year) to 0.38 (all time), reflecting how their relationship changes across market environments.

CURE vs. ERX - Sectors Allocation Comparison


Sectors
CURE
ERX

Healthcare

100.0%

-

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

100.0%

Financial Services

-

-

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

CURE
100.0%
ERX

-

Basic Materials

CURE

-

ERX

-

Communication Services

CURE

-

ERX

-

Consumer Cyclical

CURE

-

ERX

-

Consumer Defensive

CURE

-

ERX

-

Energy

CURE

-

ERX
100.0%

Financial Services

CURE

-

ERX

-

Industrials

CURE

-

ERX

-

Real Estate

CURE

-

ERX

-

Technology

CURE

-

ERX

-

Utilities

CURE

-

ERX

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CURE vs. ERX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CURE
CURE Risk / Return Rank: 2323
Overall Rank
CURE Sharpe Ratio Rank: 2222
Sharpe Ratio Rank
CURE Sortino Ratio Rank: 2626
Sortino Ratio Rank
CURE Omega Ratio Rank: 2323
Omega Ratio Rank
CURE Calmar Ratio Rank: 2323
Calmar Ratio Rank
CURE Martin Ratio Rank: 2121
Martin Ratio Rank

ERX
ERX Risk / Return Rank: 6868
Overall Rank
ERX Sharpe Ratio Rank: 7575
Sharpe Ratio Rank
ERX Sortino Ratio Rank: 6262
Sortino Ratio Rank
ERX Omega Ratio Rank: 5757
Omega Ratio Rank
ERX Calmar Ratio Rank: 8181
Calmar Ratio Rank
ERX Martin Ratio Rank: 6363
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CURE vs. ERX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and Direxion Daily Energy Bull 2X Shares (ERX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CUREERXDifference
Sharpe ratioReturn per unit of total volatility

-1.49

Sortino ratioReturn per unit of downside risk

-1.30

Omega ratioGain probability vs. loss probability

1.15

1.32

-0.18

Calmar ratioReturn relative to maximum drawdown

0.98

3.83

-2.85

Martin ratioReturn relative to average drawdown

2.24

10.23

-7.99

CURE vs. ERX - Sharpe Ratio Comparison

The current CURE Sharpe Ratio is 0.69, which is lower than the ERX Sharpe Ratio of 2.18. The chart below compares the historical Sharpe Ratios of CURE and ERX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


CUREERXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.69

2.18

-1.49

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.04

0.55

-0.51

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.26

-0.13

+0.40

Sharpe Ratio (All Time)

Calculated using the full available price history

0.48

-0.09

+0.56

Drawdowns

CURE vs. ERX - Drawdown Comparison

The maximum CURE drawdown since its inception was -69.19%, smaller than the maximum ERX drawdown of -99.54%. Use the drawdown chart below to compare losses from any high point for CURE and ERX.


Loading charts...

Drawdown Indicators


CUREERXDifference

Max Drawdown

Largest peak-to-trough decline

-69.19%

-99.54%

+30.35%

Max Drawdown (1Y)

Largest decline over 1 year

-31.10%

-23.34%

-7.76%

Max Drawdown (3Y)

Largest decline over 3 years

-51.93%

-42.34%

-9.59%

Max Drawdown (5Y)

Largest decline over 5 years

-52.23%

-46.90%

-5.33%

Max Drawdown (10Y)

Largest decline over 10 years

-69.19%

-98.59%

+29.40%

Current Drawdown

Current decline from peak

-28.51%

-91.71%

+63.20%

Average Drawdown

Average peak-to-trough decline

-18.15%

-67.04%

+48.89%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.57%

8.73%

+4.84%

Volatility

CURE vs. ERX - Volatility Comparison

Direxion Daily Healthcare Bull 3x Shares (CURE) and Direxion Daily Energy Bull 2X Shares (ERX) have volatilities of 14.68% and 14.00%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CUREERXDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.68%

14.00%

+0.68%

Volatility (6M)

Calculated over the trailing 6-month period

31.01%

33.45%

-2.44%

Volatility (1Y)

Calculated over the trailing 1-year period

44.18%

41.05%

+3.13%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

43.88%

52.01%

-8.13%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

49.60%

69.14%

-19.54%

CURE vs. ERX - Expense Ratio Comparison

CURE has a 1.08% expense ratio, which is lower than ERX's 1.09% expense ratio.


Dividends

CURE vs. ERX - Dividend Comparison

CURE's dividend yield for the trailing twelve months is around 1.18%, less than ERX's 1.63% yield.


PositionTTM202520242023202220212020201920182017
CURE
Direxion Daily Healthcare Bull 3x Shares
1.18%1.12%1.17%2.02%0.38%0.02%0.17%0.40%0.70%0.18%
ERX
Direxion Daily Energy Bull 2X Shares
1.63%2.54%2.94%3.17%2.23%2.16%2.35%1.56%3.10%0.85%

Frequently Asked Questions


CURE and ERX have a correlation of -0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CURE has higher volatility (14.68%) compared to ERX (14.00%). In terms of maximum drawdown, CURE dropped -69.19% vs ERX's -99.54%.

On 10-year performance, CURE leads with 13.02% vs -9.26% for ERX. On fees, CURE is cheaper at 1.08% per year. On volatility, ERX has been the lower-risk option at 14.00%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, CURE has performed better with a 13.02% return vs -9.26%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

CURE is cheaper with a 1.08% expense ratio, compared with 1.09% for ERX.

ERX has the higher dividend yield at 1.63%, compared with 1.18% for CURE.

CURE tracks Health Care Select Sector Index (300%), while ERX tracks Energy Select Sector Index (300%). Their fees differ too: 1.08% for CURE and 1.09% for ERX.

ERX currently has the higher Sharpe Ratio (2.18 vs 0.69), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CURE and ERX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer